
Global Stem Cell Preparation Market Growth (Status and Outlook) 2024-2030
Description
Global Stem Cell Preparation Market Growth (Status and Outlook) 2024-2030
Stem cell preparation technology refers to a series of scientific methods and procedures for obtaining, separating, purifying, expanding and maintaining the activity of stem cells from different sources, and inducing their differentiation into specific types of cells. Neural stem cells (NSCs) are stem cells with the ability of self-renewal and the potential of differentiation. These characteristics make stem cells have great application value in regenerative medicine, disease treatment, drug development and basic science research.
The global Stem Cell Preparation market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Stem Cell Preparation Industry Forecast” looks at past sales and reviews total world Stem Cell Preparation sales in 2022, providing a comprehensive analysis by region and market sector of projected Stem Cell Preparation sales for 2023 through 2029. With Stem Cell Preparation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stem Cell Preparation industry.
This Insight Report provides a comprehensive analysis of the global Stem Cell Preparation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Stem Cell Preparation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Stem Cell Preparation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stem Cell Preparation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stem Cell Preparation.
United States market for Stem Cell Preparation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Stem Cell Preparation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Stem Cell Preparation is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Stem Cell Preparation players cover Seres Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Stem Cell Preparation market by product type, application, key players and key regions and countries.
Segmentation by Type:
Embryonic Stem Cell
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells
Segmentation by Application:
Regenerative Medicine
Disease Treatment
Hairdressing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Embryonic Stem Cell
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells
Segmentation by Application:
Regenerative Medicine
Disease Treatment
Hairdressing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Seres Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda
CBR
ViaCord
Esperite
LifeCell
CCBC
STEMCELL Technologies
Zhongyuan Concord
Boya Bio
Beike Biology
International Medical
International Cord Blood Bank
Hans United Group
Qingdao Oak Biotech
Beijing Beiqi Biomedicine
Huaxin Biology
Wuhan Jiachuang Biotechnology
Xiamen Star Nuokang Cell Technology
Guangzhou Celera Stem Cell Technology
Beijing Daji Kanghua Biotechnology
Cellverse
Beijing Jiuzhitang Meike
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
171 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Stem Cell Preparation Market Size 2019-2030
- 2.1.2 Stem Cell Preparation Market Size CAGR by Region (2019 VS 2023 VS 2030)
- 2.1.3 World Current & Future Analysis for Stem Cell Preparation by Country/Region, 2019, 2023 & 2030
- 2.2 Stem Cell Preparation Segment by Type
- 2.2.1 Embryonic Stem Cell
- 2.2.2 Adult Stem Cells
- 2.2.3 Induced Pluripotent Stem Cells
- 2.2.4 Mesenchymal Stem Cells
- 2.3 Stem Cell Preparation Market Size by Type
- 2.3.1 Stem Cell Preparation Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Stem Cell Preparation Market Size Market Share by Type (2019-2024)
- 2.4 Stem Cell Preparation Segment by Application
- 2.4.1 Regenerative Medicine
- 2.4.2 Disease Treatment
- 2.4.3 Hairdressing
- 2.4.4 Others
- 2.5 Stem Cell Preparation Market Size by Application
- 2.5.1 Stem Cell Preparation Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Stem Cell Preparation Market Size Market Share by Application (2019-2024)
- 3 Stem Cell Preparation Market Size by Player
- 3.1 Stem Cell Preparation Market Size Market Share by Player
- 3.1.1 Global Stem Cell Preparation Revenue by Player (2019-2024)
- 3.1.2 Global Stem Cell Preparation Revenue Market Share by Player (2019-2024)
- 3.2 Global Stem Cell Preparation Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Stem Cell Preparation by Region
- 4.1 Stem Cell Preparation Market Size by Region (2019-2024)
- 4.2 Global Stem Cell Preparation Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Stem Cell Preparation Market Size Growth (2019-2024)
- 4.4 APAC Stem Cell Preparation Market Size Growth (2019-2024)
- 4.5 Europe Stem Cell Preparation Market Size Growth (2019-2024)
- 4.6 Middle East & Africa Stem Cell Preparation Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Stem Cell Preparation Market Size by Country (2019-2024)
- 5.2 Americas Stem Cell Preparation Market Size by Type (2019-2024)
- 5.3 Americas Stem Cell Preparation Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Stem Cell Preparation Market Size by Region (2019-2024)
- 6.2 APAC Stem Cell Preparation Market Size by Type (2019-2024)
- 6.3 APAC Stem Cell Preparation Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Stem Cell Preparation Market Size by Country (2019-2024)
- 7.2 Europe Stem Cell Preparation Market Size by Type (2019-2024)
- 7.3 Europe Stem Cell Preparation Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Stem Cell Preparation by Region (2019-2024)
- 8.2 Middle East & Africa Stem Cell Preparation Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Stem Cell Preparation Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Stem Cell Preparation Market Forecast
- 10.1 Global Stem Cell Preparation Forecast by Region (2025-2030)
- 10.1.1 Global Stem Cell Preparation Forecast by Region (2025-2030)
- 10.1.2 Americas Stem Cell Preparation Forecast
- 10.1.3 APAC Stem Cell Preparation Forecast
- 10.1.4 Europe Stem Cell Preparation Forecast
- 10.1.5 Middle East & Africa Stem Cell Preparation Forecast
- 10.2 Americas Stem Cell Preparation Forecast by Country (2025-2030)
- 10.2.1 United States Market Stem Cell Preparation Forecast
- 10.2.2 Canada Market Stem Cell Preparation Forecast
- 10.2.3 Mexico Market Stem Cell Preparation Forecast
- 10.2.4 Brazil Market Stem Cell Preparation Forecast
- 10.3 APAC Stem Cell Preparation Forecast by Region (2025-2030)
- 10.3.1 China Stem Cell Preparation Market Forecast
- 10.3.2 Japan Market Stem Cell Preparation Forecast
- 10.3.3 Korea Market Stem Cell Preparation Forecast
- 10.3.4 Southeast Asia Market Stem Cell Preparation Forecast
- 10.3.5 India Market Stem Cell Preparation Forecast
- 10.3.6 Australia Market Stem Cell Preparation Forecast
- 10.4 Europe Stem Cell Preparation Forecast by Country (2025-2030)
- 10.4.1 Germany Market Stem Cell Preparation Forecast
- 10.4.2 France Market Stem Cell Preparation Forecast
- 10.4.3 UK Market Stem Cell Preparation Forecast
- 10.4.4 Italy Market Stem Cell Preparation Forecast
- 10.4.5 Russia Market Stem Cell Preparation Forecast
- 10.5 Middle East & Africa Stem Cell Preparation Forecast by Region (2025-2030)
- 10.5.1 Egypt Market Stem Cell Preparation Forecast
- 10.5.2 South Africa Market Stem Cell Preparation Forecast
- 10.5.3 Israel Market Stem Cell Preparation Forecast
- 10.5.4 Turkey Market Stem Cell Preparation Forecast
- 10.6 Global Stem Cell Preparation Forecast by Type (2025-2030)
- 10.7 Global Stem Cell Preparation Forecast by Application (2025-2030)
- 10.7.1 GCC Countries Market Stem Cell Preparation Forecast
- 11 Key Players Analysis
- 11.1 Seres Therapeutics
- 11.1.1 Seres Therapeutics Company Information
- 11.1.2 Seres Therapeutics Stem Cell Preparation Product Offered
- 11.1.3 Seres Therapeutics Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Seres Therapeutics Main Business Overview
- 11.1.5 Seres Therapeutics Latest Developments
- 11.2 NuVasive
- 11.2.1 NuVasive Company Information
- 11.2.2 NuVasive Stem Cell Preparation Product Offered
- 11.2.3 NuVasive Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 NuVasive Main Business Overview
- 11.2.5 NuVasive Latest Developments
- 11.3 Chiesi Pharmaceuticals
- 11.3.1 Chiesi Pharmaceuticals Company Information
- 11.3.2 Chiesi Pharmaceuticals Stem Cell Preparation Product Offered
- 11.3.3 Chiesi Pharmaceuticals Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Chiesi Pharmaceuticals Main Business Overview
- 11.3.5 Chiesi Pharmaceuticals Latest Developments
- 11.4 Medi-post
- 11.4.1 Medi-post Company Information
- 11.4.2 Medi-post Stem Cell Preparation Product Offered
- 11.4.3 Medi-post Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 Medi-post Main Business Overview
- 11.4.5 Medi-post Latest Developments
- 11.5 JCR Pharmaceutical
- 11.5.1 JCR Pharmaceutical Company Information
- 11.5.2 JCR Pharmaceutical Stem Cell Preparation Product Offered
- 11.5.3 JCR Pharmaceutical Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 JCR Pharmaceutical Main Business Overview
- 11.5.5 JCR Pharmaceutical Latest Developments
- 11.6 MolMed
- 11.6.1 MolMed Company Information
- 11.6.2 MolMed Stem Cell Preparation Product Offered
- 11.6.3 MolMed Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 MolMed Main Business Overview
- 11.6.5 MolMed Latest Developments
- 11.7 Pharmicell
- 11.7.1 Pharmicell Company Information
- 11.7.2 Pharmicell Stem Cell Preparation Product Offered
- 11.7.3 Pharmicell Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 Pharmicell Main Business Overview
- 11.7.5 Pharmicell Latest Developments
- 11.8 Anterogen
- 11.8.1 Anterogen Company Information
- 11.8.2 Anterogen Stem Cell Preparation Product Offered
- 11.8.3 Anterogen Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Anterogen Main Business Overview
- 11.8.5 Anterogen Latest Developments
- 11.9 Takeda
- 11.9.1 Takeda Company Information
- 11.9.2 Takeda Stem Cell Preparation Product Offered
- 11.9.3 Takeda Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Takeda Main Business Overview
- 11.9.5 Takeda Latest Developments
- 11.10 CBR
- 11.10.1 CBR Company Information
- 11.10.2 CBR Stem Cell Preparation Product Offered
- 11.10.3 CBR Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 CBR Main Business Overview
- 11.10.5 CBR Latest Developments
- 11.11 ViaCord
- 11.11.1 ViaCord Company Information
- 11.11.2 ViaCord Stem Cell Preparation Product Offered
- 11.11.3 ViaCord Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.11.4 ViaCord Main Business Overview
- 11.11.5 ViaCord Latest Developments
- 11.12 Esperite
- 11.12.1 Esperite Company Information
- 11.12.2 Esperite Stem Cell Preparation Product Offered
- 11.12.3 Esperite Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.12.4 Esperite Main Business Overview
- 11.12.5 Esperite Latest Developments
- 11.13 LifeCell
- 11.13.1 LifeCell Company Information
- 11.13.2 LifeCell Stem Cell Preparation Product Offered
- 11.13.3 LifeCell Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.13.4 LifeCell Main Business Overview
- 11.13.5 LifeCell Latest Developments
- 11.14 CCBC
- 11.14.1 CCBC Company Information
- 11.14.2 CCBC Stem Cell Preparation Product Offered
- 11.14.3 CCBC Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.14.4 CCBC Main Business Overview
- 11.14.5 CCBC Latest Developments
- 11.15 STEMCELL Technologies
- 11.15.1 STEMCELL Technologies Company Information
- 11.15.2 STEMCELL Technologies Stem Cell Preparation Product Offered
- 11.15.3 STEMCELL Technologies Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.15.4 STEMCELL Technologies Main Business Overview
- 11.15.5 STEMCELL Technologies Latest Developments
- 11.16 Zhongyuan Concord
- 11.16.1 Zhongyuan Concord Company Information
- 11.16.2 Zhongyuan Concord Stem Cell Preparation Product Offered
- 11.16.3 Zhongyuan Concord Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.16.4 Zhongyuan Concord Main Business Overview
- 11.16.5 Zhongyuan Concord Latest Developments
- 11.17 Boya Bio
- 11.17.1 Boya Bio Company Information
- 11.17.2 Boya Bio Stem Cell Preparation Product Offered
- 11.17.3 Boya Bio Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.17.4 Boya Bio Main Business Overview
- 11.17.5 Boya Bio Latest Developments
- 11.18 Beike Biology
- 11.18.1 Beike Biology Company Information
- 11.18.2 Beike Biology Stem Cell Preparation Product Offered
- 11.18.3 Beike Biology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.18.4 Beike Biology Main Business Overview
- 11.18.5 Beike Biology Latest Developments
- 11.19 International Medical
- 11.19.1 International Medical Company Information
- 11.19.2 International Medical Stem Cell Preparation Product Offered
- 11.19.3 International Medical Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.19.4 International Medical Main Business Overview
- 11.19.5 International Medical Latest Developments
- 11.20 International Cord Blood Bank
- 11.20.1 International Cord Blood Bank Company Information
- 11.20.2 International Cord Blood Bank Stem Cell Preparation Product Offered
- 11.20.3 International Cord Blood Bank Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.20.4 International Cord Blood Bank Main Business Overview
- 11.20.5 International Cord Blood Bank Latest Developments
- 11.21 Hans United Group
- 11.21.1 Hans United Group Company Information
- 11.21.2 Hans United Group Stem Cell Preparation Product Offered
- 11.21.3 Hans United Group Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.21.4 Hans United Group Main Business Overview
- 11.21.5 Hans United Group Latest Developments
- 11.22 Qingdao Oak Biotech
- 11.22.1 Qingdao Oak Biotech Company Information
- 11.22.2 Qingdao Oak Biotech Stem Cell Preparation Product Offered
- 11.22.3 Qingdao Oak Biotech Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.22.4 Qingdao Oak Biotech Main Business Overview
- 11.22.5 Qingdao Oak Biotech Latest Developments
- 11.23 Beijing Beiqi Biomedicine
- 11.23.1 Beijing Beiqi Biomedicine Company Information
- 11.23.2 Beijing Beiqi Biomedicine Stem Cell Preparation Product Offered
- 11.23.3 Beijing Beiqi Biomedicine Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.23.4 Beijing Beiqi Biomedicine Main Business Overview
- 11.23.5 Beijing Beiqi Biomedicine Latest Developments
- 11.24 Huaxin Biology
- 11.24.1 Huaxin Biology Company Information
- 11.24.2 Huaxin Biology Stem Cell Preparation Product Offered
- 11.24.3 Huaxin Biology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.24.4 Huaxin Biology Main Business Overview
- 11.24.5 Huaxin Biology Latest Developments
- 11.25 Wuhan Jiachuang Biotechnology
- 11.25.1 Wuhan Jiachuang Biotechnology Company Information
- 11.25.2 Wuhan Jiachuang Biotechnology Stem Cell Preparation Product Offered
- 11.25.3 Wuhan Jiachuang Biotechnology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.25.4 Wuhan Jiachuang Biotechnology Main Business Overview
- 11.25.5 Wuhan Jiachuang Biotechnology Latest Developments
- 11.26 Xiamen Star Nuokang Cell Technology
- 11.26.1 Xiamen Star Nuokang Cell Technology Company Information
- 11.26.2 Xiamen Star Nuokang Cell Technology Stem Cell Preparation Product Offered
- 11.26.3 Xiamen Star Nuokang Cell Technology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.26.4 Xiamen Star Nuokang Cell Technology Main Business Overview
- 11.26.5 Xiamen Star Nuokang Cell Technology Latest Developments
- 11.27 Guangzhou Celera Stem Cell Technology
- 11.27.1 Guangzhou Celera Stem Cell Technology Company Information
- 11.27.2 Guangzhou Celera Stem Cell Technology Stem Cell Preparation Product Offered
- 11.27.3 Guangzhou Celera Stem Cell Technology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.27.4 Guangzhou Celera Stem Cell Technology Main Business Overview
- 11.27.5 Guangzhou Celera Stem Cell Technology Latest Developments
- 11.28 Beijing Daji Kanghua Biotechnology
- 11.28.1 Beijing Daji Kanghua Biotechnology Company Information
- 11.28.2 Beijing Daji Kanghua Biotechnology Stem Cell Preparation Product Offered
- 11.28.3 Beijing Daji Kanghua Biotechnology Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.28.4 Beijing Daji Kanghua Biotechnology Main Business Overview
- 11.28.5 Beijing Daji Kanghua Biotechnology Latest Developments
- 11.29 Cellverse
- 11.29.1 Cellverse Company Information
- 11.29.2 Cellverse Stem Cell Preparation Product Offered
- 11.29.3 Cellverse Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.29.4 Cellverse Main Business Overview
- 11.29.5 Cellverse Latest Developments
- 11.30 Beijing Jiuzhitang Meike
- 11.30.1 Beijing Jiuzhitang Meike Company Information
- 11.30.2 Beijing Jiuzhitang Meike Stem Cell Preparation Product Offered
- 11.30.3 Beijing Jiuzhitang Meike Stem Cell Preparation Revenue, Gross Margin and Market Share (2019-2024)
- 11.30.4 Beijing Jiuzhitang Meike Main Business Overview
- 11.30.5 Beijing Jiuzhitang Meike Latest Developments
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.